Verastem | VSTM - Debt

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $66.79M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
AstraZeneca USD 32.63B 207M Sep/2025
Curis USD 0 0 Jun/2022
Cytokinetics USD 858.06M 199.93M Jun/2025
Gilead Sciences USD 24.94B 5M Sep/2025
Incyte USD 41.27M 1.14M Sep/2025
Laboratory Of America USD 6.55B 26.4M Jun/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
TG Therapeutics USD 245.34M 8.38M Sep/2025
Verastem USD 66.79M 26.7M Sep/2024